IDeA Networks of Biomedical Research Excellence (INBRE) (P20) | PAR 17 160

Opportunity Information: Apply for PAR 17 160

The IDeA Networks of Biomedical Research Excellence (INBRE) (P20) opportunity is a discretionary grant program offered by the National Institute of General Medical Sciences (NIGMS) within the National Institutes of Health (NIH). It is designed for institutions located in IDeA-eligible states and focuses on building long-term, statewide biomedical research strength. In practical terms, INBRE funding is meant to help states that historically receive a smaller share of NIH research dollars expand their research infrastructure, develop investigators, and create durable research partnerships that raise overall competitiveness for future federal biomedical funding.

The core purpose of INBRE is capacity building at the state level rather than funding a single stand-alone research project. NIGMS is looking for applications that strengthen biomedical research ecosystems by connecting a state’s research-intensive organizations with a broader network of partners. This network-based model encourages collaboration between major research universities or independent biomedical research institutes and other institutions that play key roles in the workforce and training pipeline, including primarily undergraduate institutions, community colleges, and Tribally Controlled Colleges and Universities (TCCUs), where appropriate. The intent is to spread research opportunity, mentorship, and infrastructure across the state, so that students and early-stage investigators at many kinds of campuses can participate in high-quality biomedical research and eventually contribute to a stronger statewide research enterprise.

Eligible applicants are biomedical research institutions in IDeA-eligible states that award doctoral degrees in the health sciences or in sciences related to health, as well as independent biomedical research institutes in those states that already maintain ongoing biomedical research programs funded by NIH or other federal agencies. The opportunity also explicitly recognizes and encourages participation from a range of institution types that often serve underrepresented or underserved populations, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and TCCUs. From an organizational eligibility standpoint, applicants may include public or state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (including both 501(c)(3) and non-501(c)(3) nonprofits), as reflected in the listing of eligible applicant categories.

The opportunity is strictly limited to U.S.-based applicants and activities. Non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. In addition, foreign components, as that term is defined in the NIH Grants Policy Statement, are not allowed under this funding announcement. This means the funded program must be planned and carried out without foreign institutional components that would meet NIH’s definition of a foreign component, reinforcing the program’s state-focused capacity-building mission.

Administratively, this opportunity is identified as Funding Opportunity Number PAR-17-160 and is associated with CFDA number 93.859, placing it within NIH’s health research funding portfolio. The funding instrument is a grant, and the activity mechanism is a P20, which commonly supports planning, development, and programmatic center-like activities rather than individual investigator-initiated R01-style projects. The original posting date in the source information is February 9, 2017, and the original closing date listed is January 24, 2018, which indicates the particular announcement summarized here reflects a specific application window for that cycle.

Overall, the INBRE (P20) program can be understood as a statewide research development initiative: it aims to grow people, partnerships, and platforms needed for strong biomedical research in IDeA-eligible states. By requiring collaboration across different types of institutions and emphasizing research engagement and infrastructure development, it is structured to expand access to research training and mentorship, increase research productivity and competitiveness, and create a coordinated network that can sustain biomedical research progress over time within the state.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "IDeA Networks of Biomedical Research Excellence (INBRE) (P20)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
• This funding opportunity was created on 2017-02-09.
• Applicants must submit their applications by 2018-01-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Others.

Apply for PAR 17 160

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: